Objective

• Using respiratory patient databases in Canada and UK, we sought to compare and contrast aspects of respiratory care. Perceptions on the value of their Spacer were also assessed.

Methods

• A survey was sent out to patients across Canada and UK who were registered in myAERO* Community, a voluntary platform for AeroChamber* Spacer (TMI) users. The survey asked whether they had annual HCP visits, did they have an Asthma / COPD action plan, and how often inhaler technique was checked, as well as differences noticed between using an MDI / Spacer system compared to an MDI alone.

Results

Condition:

• 2007 Canadian patients (82% Asthma, 18% COPD) and 294 UK patients (72% Asthma, 28% COPD) completed the survey.

Respiratory Patient Care:

• 68% of patients in Canada selected having an annual visit with a healthcare provider, compared to 88% in the UK. 53% and 35% of Canadian patients had a defined action plan and inhaler technique check (annually or every other visit), respectively, while 73% of UK patients reported the same.

Perceived differences using an MDI / Spacer system versus an MDI alone:

• 79% of patients in Canada and 80% in UK reported greater confidence in medication delivery when using a spacer with their pressurized metered dose inhaler. 23% of patients in Canada and 20% of patients in the UK reported needing fewer inhaler puffs. 9% of Canadian patients and 10% of UK patients perceived fewer emergency visits, while 10% in Canada and 14% in the UK experienced fewer side effects, respectively.